Article info
PDFSection 4: Clinical Pharmacy Services
4CPS-121 Evaluation of cost and efficacy of eculizumab in complement mediated thrombotic microangiopathy in the clinical setting
Citation
4CPS-121 Evaluation of cost and efficacy of eculizumab in complement mediated thrombotic microangiopathy in the clinical setting
Publication history
- First published March 24, 2020.
Online issue publication
August 05, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.